1. Comparing outcomes of patients with epidermal growth factor receptor (EGFR) therapy resistant mutations (EXON 20 and T790M). (January 2019) Authors: Enver, M.; Khalid, F.; Khan, S.; Ahmed, S. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunotherapy outcomes based on PDL1 expression and tissue origin in NSCLC. (January 2019) Authors: Khan, S.; Charalambous, M.; Khan, M.; Khalid, F.; Enver, M.; Ahmed, S. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcomes for patients with NSCLC on immunotherapy treatment (adenocarcinoma). (January 2019) Authors: Khalid, F.; Weston, C.; Enver, M.; Khan, S.; Ahmed, S. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗